[1] Bernal W,Wendon J.Acute liver failure. New Engl J Med,2013,369(26):2525-2534. [2] Bernal W,Lee W M,Wendon J,et al. Acute liver failure: A curable disease by 2024 J Hepatol,2015,62(1):S112-S120. [3] Bernal W,Auzinqer G,Dhawan A,et al.Acute liver failure. Lancet,2010,376(9736):190-201. [4] Lee WM,Squires RH,Nyberq SL,et al.Acute liver failure: summary of a workshop. Hepatology,2008,47(4):1401-1415. [5] Mcphail M J,Kriese S,Heneghan M A.Current management of acute liver failure. Curr Opin Gastroenterol,2015,31(3): 209-214. [6] Singanayagam A,Bernal W.Update on acute liver failure. Curr Opin Crit Care,2015,21(2):134-141. [7] Istvan ES,Deisenhofer J.Structural mechanism for statin inhibition of HMG CoA reductase. Science,2001, 292(5519): 1160-1164. [8] Kawai K,Kamochi R,Oiki S,et al.Probiotics in human gut microbiota can degrade host glycosaminoglycans. Scient Rep,2018,8(1):1-13. [9] 高小玲,汪保英,尹素改,等. 白术内酯对IEC-6细胞及食管癌细胞ECA9706增殖能力的影响. 中华中医药杂志,2015,30(3):921-923. [10] 崔运浩,梁茂新,初志. 白芍潜在功能发掘与利用. 中华中医药学刊,2016,34(5):1240-1243. [11] 徐飞,林锦培,李璐璐,等. 赤芍对慢性阻塞性肺疾病大鼠气道重塑的影响及机制研究. 中华中医药杂志,2017,32(4):1755-1760. [12] Grek A,Arasi L.Acute liver Failure. AACN Adv Crit Care,2016,27(4):420-429. [13] Patel P,Okoronkwo N, Pyrsopoulos N.Future approaches and therapeutic modalities for acute liver failure. Clin Liver Dis,2018,22(2):419-427. [14] Wang YH,Wu DB,Chen B,et al.Progress in mesenchymal stell cell-based therapy for acute liver failure. Stell Cell Res Ther,2018,9(2):227. [15] Bernal W,Jalan R,Quaglia A,et al.Acute-on-chronic liver failure. Lancet,2015,386(10003):1576-1587. [16] Tao YC,Wang ML,Chen EQ,et al.Stem cells transplantations in the treatment of patients with liver failure. Curr Stem Cell Res Ther,2018,13(3):193-201. [17] Gibson GR,Roberfroid MB.Dietary modulation of the human colonic microbiota introducing the concept of prebiotics. J Nutr, 1995,125(6):1401-1402. [18] Takaya H,Yoshiji H,Kawaratani H,et al.Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure. Biomed Rep,2017,7(3):277-285. [19] Hugenholtz GC,Adelmeijer J,Meijers JC,et al.An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure:implications for hemostasis and clinical outcome. Hepatology,2013,58(2):752-761. [20] Li Y,Wang X,Wei Z,et al.Pretreatment with wortmannin alleviates lipopolysacchrirde/d-galactosamine-induced acute live injury. Biochem Biophy Res Commun,2014,455(3-4):234-240. |